The effects of ginger supplementation on common gastrointestinal symptoms in patients with relapsing-remitting multiple sclerosis: a double-blind randomized placebo-controlled trial.

Sahar FoshatiMaryam PoursadeghfardZahra HeidariReza Amani

Published in: BMC complementary medicine and therapies (2023)

This trial was prospectively registered at the Iranian Registry of Clinical Trials ( www.irct.ir ) under the registration number IRCT20180818040827N3 on 06/10/2021.

Keyphrases

multiple sclerosis
double blind
clinical trial
phase iii
phase ii
placebo controlled
study protocol
open label
white matter
sleep quality
depressive symptoms
rheumatoid arthritis